Immunohistochemical demonstration of gonadotropin-releasing hormone receptors in prostate carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 23, Issue 6, 2005, Pages 399-401

  Szabó, Janos ^a   Végh, Attila ^a   Rácz, Gergo ^b   Szende, Béla ^b  

^a Central Hospital of the Hungarian Army   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Carcinoma; Gonadotropin releasing hormone receptor; Immunoperoxidase; Prostate

Indexed keywords

ANDROGEN RECEPTOR; GONADORELIN; GONADORELIN RECEPTOR; PARAFFIN; PEROXIDASE;

ARTICLE; CANCER STAGING; CORRELATION ANALYSIS; FROZEN SECTION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; SAMPLE;

AGED; AGED, 80 AND OVER; CELL NUCLEUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, LHRH;

EID: 27844465409     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2005.04.001     Document Type: Article

References (19)

1. A.M. Comaru-Schally, A.V. Schally Rational use of agonists and antagonists of luteinizing hormone-releasing hormone (LH-RH) in the treatment of hormone-sensitive neoplasms and gynaecologic conditions Adv Drug Deliv Rev 28 1997 157 169
2. N. Bruchovsky, S.L. Goldenberg, K. Akakura Luteinizing hormone-releasing hormone agonists in prostate cancer Cancer 72 1993 1685 1691
3. H. Parmar, R.H. Phillips, S.L. Lightman Randomised controlled study of orchidectomy vs. long-acting D-Trp-6-LH-RH microcapsules in advanced prostatic carcinoma Lancet 2 1985 1201 1205
4. A. Schally, A.M. Comaru-Schally Hypothalamic and other peptide hormones J.F. Holland E. Frei III R.C. Bast Jr Cancer medicine 4th ed 1997 Williams and Wilkins Baltimore (MD) 1067 1086 [chapter 71]
5. G. Emons, O. Ortmann, K.-D. Schulz Growth-inhibitory actions of analogues of luteinizing hormone releasing hormone on tumour cells Trends Endocrinol Metab 8 1997 355 359
6. M. Fekete, T.W. Redding, A.M. Comaru-Schally Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia Prostate 14 1989 191 208
7. P. Limonta, D. Dondi, R.M. Moretti Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP J Clin Endocrinol Metab 75 1992 207 212
8. A. Qayum, W. Gullick, R.C. Clayton The effect of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors Br J Cancer 62 1990 96 99
9. D. Dondi, P. Limonta, R.M. Moretti Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH agonists on human androgen-independent prostate cancer cell line DU 145 Evidence for an autocrine-inhibitory LHRH loop Cancer Res 54 1994 4091 4095
10. G. Srkalovic, L. Bokser, S. Radulovic Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R-3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75 Endocrinology 127 1990 3052 3060
11. J. Pinski, H. Reile, G. Halmos Inhibitory effects of analogs of luteinizing hormone-releasing hormone on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer Int J Cancer 59 1994 51 55
12. G. Halmos, J.M. Arencibia, A.V. Schally High incidence of receptors for luteinizing hormone releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers J Urol 163 2000 623 629
13. J.Y. Bahk, J.S. Hyun, H. Lee Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells Urol Res 26 1998 259 264
14. P. Limonta, R.M. Moretti, M.M. Marelli The luteinizing hormone-releasing hormone receptor in human prostate cancer cells Messenger ribonucleic acid expression, molecular size and signal transduction pathway Endocrinology 140 1999 5250 5256
15. B. Szende, I. Romics, K. Minik Repeated biopsies in evaluation of therapeutic effects in prostate carcinoma Prostate 49 2001 93 100
16. J. Szabó, K. Bartók, T. Kerényi 2000 Follow-up of prostate carcinoma patients treated with total androgen blockade by repeated map biopsy Ann Urol (Paris) 34 2000 236 239
17. B. Szende, S. Lovász, P. Farid Apoptosis in prostate carcinomas after short-term treatment with Decapeptyl Ann N Y Acad Sci 140 2003 784 788
18. C. Damyanov Treatment of an orchiectomized patient with hormone refractory prostate cancer with LHRH agonists Eur Urol 40 2001 474 477
19. G. Emons, V. Müller, O. Ortmann Effects of LHRH-analogues on mitogenic signal transduction in cancer cells J Steroid Biochem Mol Biol 65 1998 199 206